178 related articles for article (PubMed ID: 34180352)
1. Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer.
Huang X; Chen C; Xu Y; Shen L; Chen Y; Su H
Bioengineered; 2021 Dec; 12(1):2688-2701. PubMed ID: 34180352
[TBL] [Abstract][Full Text] [Related]
2. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
Front Immunol; 2021; 12():769685. PubMed ID: 35003085
[TBL] [Abstract][Full Text] [Related]
3. CSRP1 expression is associated with a mesenchymal, stroma-rich tumor profile and poor prognosis in colon cancer.
Demirkol Canli S
Turk J Med Sci; 2023; 53(6):1678-1689. PubMed ID: 38813484
[TBL] [Abstract][Full Text] [Related]
4. AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma.
Li D; Liu Z; Ding X; Qin Z
Biomed Res Int; 2021; 2021():3108933. PubMed ID: 34938806
[TBL] [Abstract][Full Text] [Related]
5. CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Woischke C; Blaj C; Schmidt EM; Lamprecht S; Engel J; Hermeking H; Kirchner T; Horst D
Oncotarget; 2016 May; 7(21):31350-60. PubMed ID: 27120783
[TBL] [Abstract][Full Text] [Related]
6. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
7. Correlation Research of Thymidine Synthase Expression in Circulating Tumor Cell and Clinical Characteristics of Colon Cancer.
Jiang Y; Liu K; Shi Y; Li Y; Ji X; Zhao R
Ann Clin Lab Sci; 2020 Jul; 50(4):439-446. PubMed ID: 32826238
[TBL] [Abstract][Full Text] [Related]
8. Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer.
Liu J; Yi J; Zhang Z; Cao D; Li L; Yao Y
Aging (Albany NY); 2021 Jun; 13(12):16513-16526. PubMed ID: 34157681
[TBL] [Abstract][Full Text] [Related]
9. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
Li X; Wen D; Li X; Yao C; Chong W; Chen H
Front Immunol; 2020; 11():1678. PubMed ID: 33013820
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.
Kang N; Xie X; Zhou X; Wang Y; Chen S; Qi R; Liu T; Jiang H
BMC Gastroenterol; 2022 Apr; 22(1):190. PubMed ID: 35429970
[TBL] [Abstract][Full Text] [Related]
13. Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9.
Buttacavoli M; Di Cara G; Roz E; Pucci-Minafra I; Feo S; Cancemi P
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830271
[TBL] [Abstract][Full Text] [Related]
14. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
Mo S; Pei Z; Dai L
Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
[No Abstract] [Full Text] [Related]
15. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
16. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.
Ning X; Wang C; Zhang M; Wang K
Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
18. A novel 6-gene signature derived from tumor-infiltrating T cells and neutrophils predicts survival of bladder urothelial carcinoma.
Zou X; Wei Y; Qi T; Wang X; Zuo W; Wang T; Zhu W; Zhou X
Aging (Albany NY); 2021 Dec; 13(23):25496-25517. PubMed ID: 34905506
[TBL] [Abstract][Full Text] [Related]
19. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
Yu J; Yang K; Zheng J; Sun X; Zhao W
Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
